To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants
Clinical trial NCT04914377 · COMPLETED
Trial details
- NCT number
- NCT04914377
- Sponsor
- Novatek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2021-12-16
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.